ML239
SIGMA/SML0442 - ≥98% (HPLC)
Synonym: (2,4,6-
CAS Number: 1378872-36-6
Empirical Formula (Hill Notation): C13H10Cl3N3O2
Molecular Weight: 346.60
MDL Number: MFCD23098913
Linear Formula: C13H10Cl3N3O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C13H10Cl3N3O2/c14-8-4- |
| InChI key | NVEDPFICKAIHKD-NGYBGAFCSA |
| Quality Level | 100 ![]() |
| SMILES string | Clc1cc(Cl)c(OCC(=O)NN=C |
| solubility | DMSO: 15 mg/mL (clear solution) |
| storage temp. | 2-8°C |
| Application: | ML239 has been used as a proble in cellular lipid profiling. |
| Biochem/physiol Actions: | ML239 decreases the saturated and monounsaturated lysophosphatidylethanolam |
| Biochem/physiol Actions: | ML239 is an inhibitor of breast cancer stem cells found from a screen using stem cell-like human mammary epithelial cells (HMLE). ML239 inhibited cancer stem cells with an IC50 of 1.16 μM with 24-fold selectivity against the control cell line. |
| Biochem/physiol Actions: | ML239 is an inhibitor of breast cancer stem cells. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332 - H315 - H319 - H335 - H400 |
| Precautionary statements | P273 - P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22-36/37/38 |
| Safety Statements | 26 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |



